CLINICAL_TRIALS
trial_result
· 2013-04-17
Clinical Trial Update: An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants [Phase 2]
Summary
Phase 2 study evaluating the efficacy and safety of tapentadol extended-release in chronic pain, including low back pain and knee osteoarthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-04-17